Oncology · External Control
Accelerating a Phase 2 rare cancer submission
Built an FDA-accepted external control arm from EHR + claims data for a precision oncology program.
8 months saved
Unlock full case studyCase studies
Evidence that moved the needle
A selection of recent engagements with biopharma partners — names omitted for confidentiality.
Full case studies are partner-confidential
Sign in to the client portal to read detailed methodology, datasets, and outcomes.
Cardiometabolic · HEOR
Payer-ready value story for a novel GLP-1
Designed budget impact and cost-effectiveness models accepted in 14 US payer reviews.
$1.2B BIM impact
Unlock full case studyNeurology · Natural History
Defining progression in an ultra-rare disease
Established the first global natural history dataset enabling regulatory engagement.
1,200 patients
Unlock full case studyImmunology · Treatment Patterns
Identifying switch triggers in IBD
Mapped real-world treatment journeys to inform medical affairs and field strategy.
12 markets
Unlock full case study